BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Gastrointest Surg. Dec 27, 2025; 17(12): 113407
Published online Dec 27, 2025. doi: 10.4240/wjgs.v17.i12.113407
Table 1 Comparison of preoperative characteristics between the two groups, n (%)/median (25th percentile, 75th percentile)/mean ± SD
Parameter
ERAS group (n = 40)
TRAD group (n = 38)
P value
Hedges (g)
Odds ratio
95%CI
Gender0.4060.660.25-1.75
    Male26 (65.00)28 (73.68)
    Female14 (35.00)10 (26.32)
Age (months)60.00 (34.75, 90.00)84.00 (39.00, 91.75)0.331-0.22-19.68 to 6.40
Weight (kg)21.35 (15.75, 26.25)25.00 (15.75, 27.00)0.420-0.18-4.60 to 1.65
ASA physical status0.4931.370.56-3.33
    Ⅱ21 (52.50)17 (44.74)
    Ⅲ19 (47.50)21 (55.26)
Laboratory indicators
    WBC (× 109/L)8.39 (6.71, 14.44)9.75 (5.89, 14.82)0.951-0.01-2.62 to 1.84
    NEUT (× 109/L)4.58 (2.70, 11.91)6.60 (3.20, 12.50)0.460-0.17-0.17 to -3.16
    CRP (mg/L)4.50 (2.50, 19.20)6.50 (4.10, 21.50)0.265-0.71-21.22 to 10.49
    Hb (g/L)123.53 ± 15.62117.03 ± 15.160.068-0.44-0.39 to 13.38
    PAB (g/L)0.24 ± 0.040.25 ± 0.040.223-0.28-0.03 to 0.01
    Glu (mmol/L)5.38 (5.01, 6.91)4.60 (4.09, 5.33)< 0.001-1.020.64-1.67
Table 2 Comparison of intraoperative characteristics between the two groups, n (%)/median (25th percentile, 75th percentile)/mean ± SD
Parameter
ERAS group (n = 40)
TRAD group (n = 38)
P value
Hedges (g)
Odds ratio
95%CI
Operation time (minutes)92.20 ± 21.3588.11 ± 17.990.3640.20-4.83 to 13.02
Blood loss (mL)10.00 (5.00, 10.00)10.00 (5.00, 10.00)0.911-0.02-2.42 to 2.94
Surgical approach0.6321.240.51, 3.04
    Wedge resection19 (47.50)16 (42.10)
    Segmental resection21 (52.50)22 (57.90)
Diverticulum location (cm)44.50 ± 18.8747.76 ± 22.570.490-0.16-12.63 to 6.10
Infusion speed (mL/kg/hour)5.00 (5.00, 6.00)8.00 (7.00, 8.75)< 0.001-1.65-2.95 to -1.53
Combined anesthesia32 (80.00)9 (23.68)< 0.00112.894.39-37.83
Catheter utilization
    NGTs19 (47.50)30 (78.95)0.0040.240.09-0.65
    Urinary catheters5 (12.50)12 (31.58)0.0410.310.10-0.99
    Abdominal drains7 (17.50)17 (44.74)0.0090.260.09-0.74
Table 3 Analysis the intra-individual correlation of pain between the two groups
Variable
β (95%CI)
t value
P value
Group (ERAS vs TRAD)-1.34 (-1.66 to -1.02)-8.251< 0.001
Time (continuous)-0.03 (-0.04 to -0.02)-7.075< 0.001
Group time0.02 (0.01-0.03)2.7510.006
Table 4 Comparison of postoperative recovery indicators, median (25th percentile, 75th percentile)
Parameter
ERAS group (n = 40)
TRAD group (n = 38)
P value
Hedges (g)
95%CI
FLACC pain scores
    2 hours2.00 (1.75, 3.00)3.00 (2.00, 4.00)< 0.001-1.09-1.32 to -0.58
    6 hours3.00 (2.75, 4.00)4.00 (4.00, 4.00)< 0.001-1.89-1.49 to -0.89
    12 hours4.00 (3.00, 4.00)5.00 (5.00, 6.00)< 0.001-2.22-2.14 to -1.41
    24 hours3.00 (3.00, 4.00)4.00 (4.00, 5.00)< 0.001-1.09-1.19 to -0.49
    36 hours3.00 (2.75, 3.00)4.00 (3.00, 4.00)< 0.001-0.83-0.92 to -0.28
    48 hours2.00 (1.00, 2.00)2.00 (2.00, 3.00)< 0.001-0.87-0.85 to -0.28
Oral analgesics (administrations)4.00 (3.75, 5.00)2.00 (1.00, 3.75)< 0.001-1.331.17-2.32
Postoperative LOS8.00 (6.00, 8.00)9.50 (8.00, 11.00)< 0.001-1.16-4.06 to -1.63
    Wedge resection8.00 (7.00, 9.00)9.00 (7.00, 11.00)0.354-0.31-2.77 to 0.31
    Segmental resection6.98 (6.00, 8.00)10.00 (9.00, 11.05)< 0.001-2.10-5.88 to -2.39
Table 5 Effects of treatment groups on length of stay before and after covariate adjustment via inverse probability weighting
Variable
β (95%CI)
t value
P value
Group (ERAS vs TRAD)1-2.88 (-4.06 to -1.70)-4.794< 0.001
Group (ERAS vs TRAD)2-2.89 (-4.06 to -1.71) -4.823< 0.001
Table 6 Comparison of postoperative outcomes of the two groups, n (%)/median (25th percentile, 75th percentile)/mean ± SD
Parameter
ERAS group (n = 40)
TRAD group (n = 38)
P value
Hedges (g)
Odds ratio
95%CI
Recovery parameters (days)
    Time to ambulation1.00 (1.00, 2.00)3.00 (2.00, 3.00)< 0.001-1.59-1.50 to -0.85
    First flatus2.00 (1.00, 2.00)3.00 (2.00, 3.75)< 0.001-1.12-1.30 to -0.58
    TEN achievements5.00 (5.00, 6.00)6.50 (6.00, 8.00)< 0.001-1.36-2.22 to -1.10
    IV duration6.00 (5.00, 6.00)8.00 (7.00, 9.00)< 0.001-1.92-3.09 to -1.68
Catheter duration (days)
    NGTs2.00 (1.50, 3.00)3.00 (3.00, 4.00)< 0.001-1.44-2.26 to -0.84
    Urinary catheters1.00 (1.00, 2.00)3.00 (2.00, 3.00)0.016-1.38-2.11 to -0.42
    Abdominal drains2.71 ± 0.764.72 ± 1.230.001-1.73-3.04 to -0.97
Complications7 (17.50)5 (13.16)0.5951.400.40-4.86
    Nausea/vomiting3 (7.50)2 (5.26)11.460.23-9.26
    Abdominal distension5 (12.50)4 (10.53)11.210.30-4.91
    Cough/sputum production2 (5.00)2 (5.26)10.950.13-7.09
    Umbilical infection1 (2.50)0 (0.00)12.920.12-74.02
    Residual abdominal infection1 (2.50)1 (2.63)10.970.06-16.15
    Anastomotic leakage0 (0.00)1 (2.63)0.4870.310.01-7.81
Clavien-Dindo classification10.890.09-9.16
    Grade I4 (10.00)3 (7.90)
    Grade II3 (7.50)2 (5.26)
Parental satisfaction37 (92.50)33 (86.84)0.4761.870.41-8.43
30-day readmission1 (2.50)1 (2.63)10.950.06-15.73
    Incomplete obstruction1 (2.50)0 (0.00)12.920.12-74.02
    Residual abdominal infection0 (0.00)1 (2.63)0.4870.310.01-7.81
Laboratory parameters
    WBC (× 109/L)9.66 ± 3.0210.62 ± 4.010.336-0.26-2.93 to 1.02
    NEUT (× 109/L)5.98 ± 2.028.01 ± 3.980.015-0.60-3.63 to -0.41
    CRP (mg/L)13.67 (7.85, 22.11)19.63 (7.10, 32.69)0.20-0.35-21.83 to 0.05
    Hb (g/L)117.82 ± 13.51114.46 ± 12.600.3480.26-3.75 to 10.46
    PAB (g/L)0.18 (0.15, 0.21)0.15 (0.13, 0.18)0.01-0.600.01-0.04
    Glu (mmol/L)5.53 (4.79, 6.43)6.46 (5.35, 8.81)0.023-0.60-2.25 to -0.03